![]() Second Quarter 2013 Earnings Release July 23, 2013 IDEX PROPRIETARY & CONFIDENTIAL Exhibit 99.1 |
![]() 2 IDEX PROPRIETARY & CONFIDENTIAL Agenda IDEX Outlook Q2 Financial Performance Q2 Segment Performance Fluid & Metering Health & Science Fire & Safety / Diversified Guidance Update Q&A |
![]() 3 Replay Information • Dial toll–free: 855.859.2056 • International: 404.537.3406 • Conference ID: #26074056 • Log on to: www.idexcorp.com IDEX PROPRIETARY & CONFIDENTIAL |
![]() 4 IDEX PROPRIETARY & CONFIDENTIAL This presentation and discussion will include forward- looking statements. Our actual performance may differ materially from that indicated or suggested by any such statements. There are a number of factors that could cause those differences, including those presented in our most recent annual report and other company filings with the SEC. Cautionary Statement Under the Private Securities Litigation Reform Act |
![]() 5 IDEX Q2 Financial Performance Revenue Organic: 2% growth 70 bps expansion 46% growth 13% growth EPS* Operating Margin* Free Cash Flow * Q2 2012 EPS / Operating Margin data adjusted for restructuring expenses ($2.6M) Outstanding EPS, Margin & FCF performance IDEX PROPRIETARY & CONFIDENTIAL |
![]() 6 IDEX PROPRIETARY & CONFIDENTIAL Fluid & Metering Orders Revenue Q2 Sales Mix: Organic 7% Acquisition 0% Fx 0% Total 7% Q2 Summary: Organic: 7% growth 280 bps expansion Organic: 10% growth Operating Margin* * Q2 2012 Operating Margin data adjusted for restructuring expense Q2 Operating margin of 24.9% up 280 bps Municipal water services showing signs of stabilization in North America Ag orders pushed out of Q1 were realized in Q2 Energy continues to see benefit of rebounding LPG market in North America Operating margin improved 280 bps on volume strength, the continued benefit of cost-out actions and disciplined management Excellent improvement in organic orders and revenue, driven by strength in Energy and Ag |
![]() 7 Health & Science Orders Revenue Organic: 2% decline 250 bps expansion Organic: 1% growth Operating Margin* * Q2 2012 Operating Margin data adjusted for restructuring expense Q2 Sales Mix: Organic -2% Acquisition 9% Fx -1% Total 6% Q2 Summary: Successfully managed costs to deliver margin expansion Organic sales declined year-over-year, but grew 2 percent sequentially Operating margins expanded 250 basis points on the strength of focused cost-out initiatives Scientific Fluidics has strengthened in North America and Europe Optics & Photonics operating margins have improved while order activity remains challenged IDEX PROPRIETARY & CONFIDENTIAL |
![]() 8 Fire & Safety/Diversified Orders Revenue Organic: 1% decline 270 bps decline Organic: 3% growth Operating Margin* * Q2 2012 Operating Margin data adjusted for restructuring expense Q2 Sales Mix: Organic -1% Acquisition 0% Fx 0% Total -1% Q2 Summary: facility consolidation IDEX PROPRIETARY & CONFIDENTIAL FSG continues to drive exceptional profitability improvements after Op margin decline due to a charge associated with a facility closure Strong organic order growth contributions from FSG and Dispensing X-Smart product continues to gain traction in emerging markets FSG & Rescue seeing pickup in Eastern European and Chinese markets |
![]() 9 IDEX PROPRIETARY & CONFIDENTIAL Outlook: 2013 Guidance Summary Q3 2013 • EPS estimate range: $0.72 – $0.74 • Organic revenue growth ~ 3 – 4% • Positive revenue impact from acquisition of ~ 2% • Operating margin ~ 19% FY 2013 – Organic revenue growth ~ 3% – Positive revenue impact from acquisition of ~ 2% – Operating margin ~ 19% – Negative Fx impact ~ 1% to sales – Tax rate ~ 29% – Cap Ex ~ $36 - $38M – Free Cash Flow will significantly exceed net income – Continued share repurchases – EPS estimate excludes future acquisitions and associated costs and charges • EPS estimate range: $2.93 – $2.98 • Other modeling items |
![]() 10 IDEX PROPRIETARY & CONFIDENTIAL Q&A |